These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 6383904)

  • 1. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
    Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
    Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
    Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
    Ebert R; Frerichs H; Creutzfeldt W
    Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
    Crockett SE; Mazzaferri EL; Cataland S
    Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients.
    Osei K; Falko JM; O'Dorisio TM; Fields PG; Bossetti B
    J Clin Endocrinol Metab; 1986 Feb; 62(2):325-30. PubMed ID: 3510224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
    J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity.
    Heptulla RA; Tamborlane WV; Cavaghan M; Bronson M; Limb C; Ma YZ; Sherwin RS; Caprio S
    Pediatr Res; 2000 May; 47(5):628-33. PubMed ID: 10813588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
    Meneilly GS; Ryan AS; Minaker KL; Elahi D
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus.
    Mazzaferri EL; Starich GH; Lardinois CK; Bowen GD
    J Clin Endocrinol Metab; 1985 Aug; 61(2):313-21. PubMed ID: 4008608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
    Krarup T; Madsbad S; Moody AJ
    J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat.
    Chan CB; Pederson RA; Buchan AM; Tubesing KB; Brown JC
    Diabetes; 1984 Jun; 33(6):536-42. PubMed ID: 6373459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ; Miller LJ; Service FJ; Go VL
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism.
    Osei K; Falko JM; O'Dorisio TM; Adam DR
    Diabetes Care; 1985; 8(5):436-9. PubMed ID: 3902421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies with gastric inhibitory polypeptide.
    Brown JC; Otte S
    World J Surg; 1979 Sep; 3(5):553-8. PubMed ID: 516774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of arginine and gastric inhibitory polypeptide on insulin release in man.
    Elahi D; Raizes GS; Andres R; Hershcopf RJ; Muller DC; Tobin JD; Andersen DK
    Am J Physiol; 1982 May; 242(5):E343-51. PubMed ID: 7044143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
    Salera M; Giacomoni P; Pironi L; Cornia G; Capelli M; Marini A; Benfenati F; Miglioli M; Barbara L
    J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects.
    Ross SA; Dupre J
    Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.